Title for MeetingAbstracts
Alphabetical listing of titles
-
Risky sexual behaviour of the members of a mobile circus team and their sexual health intervention through networking.
-
Risky sexual practices amongst MSM in public sex environment in Dhaka of Bangladesh.
-
Risky sexual practices of northern Thai men and women: preliminary results.
-
Risperidone versus 'conventional' anti-psychotic medication for schizophrenia - a systematic review.
-
Ritonavir (RIT) pharmacokinetics (PK) during combination therapy with delavirdine (DLV).
-
Ritonavir (RTV) low dosages increases dramatically the saquinavir (SQV-HGC) bioavailability: a PK study in healthy volunteers (HV).
-
Ritonavir (RTV) pharmacokinetics and dose requirements in HIV infected children < two years of age.
-
Ritonavir (RTV) Trough Plasma Concentrations (Cmin) in RTV Low Dose Boosted Protease Inhibitors (PI) Containing Regimen and Their Use for Therapeutic Drug Monitoring in HIV-Infected Patients (Pts).
-
Ritonavir (RTV), decreases meperidine exposure in HIV-negative subjects.
-
Ritonavir (RTV)-saquinavir (SQV) in protease inhibitor-naive patients after 72 weeks. M97-462 Study Group.
-
Ritonavir + saquinavir (RIT + SAQ) salvage therapy in antiretroviral-experienced patients.
-
Ritonavir + saquinavir + 2 NRTIs as first line HAART therapy: 21 patients from Cook County Hospital, Chicago.
-
Ritonavir + saquinavir as a rescue therapy after indinavir failure.
-
Ritonavir Accumulates into Cultured Human Adipocytes and Alters Insulin Resistance Related Adipocytokines Levels.
-
Ritonavir boosted double protease inhibitors in salvage therapy.
-
Ritonavir clinical benefit correlates with HIV RNA and CD4 cell levels in advanced HIV illness.
-
Ritonavir does not increase methadone exposure in healthy volunteers.
-
Ritonavir Exhibits Anti-Atherogenic Properties on Vascular Smooth Muscle Cells.
-
Ritonavir in combination with 2 Reverse Transcriptase Inhibitors (RTI) in HIV infected children:long term results.
-
Ritonavir intensification in indinavir recipients with detectable HIV RNA levels.
-
Ritonavir intensification in indinavir recipients: Tolerance, antiviral effect and pharmokinetics.
-
Ritonavir pharmacokinetics in HIV-infected patients with underlying hepatic disease.
-
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients. The Swiss HIV Cohort Study.
-
Ritonavir promotes increased growth in HIV-infected children.
-
Ritonavir, AZT, DDC, as a triple combination in AIDS patients.
-
Ritonavir, saquinavir, and nevirapine as a salvage regimen for indinavir or ritonavir resistance.
-
Ritonavir, stavudine (d4T), didanosine (ddI) as a triple combination treatment in antiretroviral - naive patients.
-
Ritonavir-containing dual protease inhibitor regimens may have synergistic antiviral effects in patients--based on in vitro model.
-
Ritonavir-indinavir combination regimen offers potential synergistic antiviral effects in addition to substantially improved pharmacokinetic profile.
-
Ritonavir-indinavir combination regimen offers potential synergistic antiviral effects in addition to substantially improved pharmacokinetic profile. Eleventh International Conference on Antiviral Research.